OBaris raises €1.1M Pre-Seed round

1 March 2024· Schlieren, Switzerland· health, drug_delivery, biotech, medical_devices, b2b, software_hardware

The funding was secured around the time of the company's founding in March 2024, to support initial operations and technology development.

Investors

LeadETH Foundation
Also participating
InnosuisseGebert Rüf StiftungUSZ FoundationEvi-Diethelm Winterle StiftungSwiss National Science Foundation SNSF

About OBaris

Stage
Seed
Headquarters
Schlieren, Switzerland
Founded
2024
Team Size
6–20
Sectors
healthdrug_deliverybiotechmedical_devicesb2bsoftware_hardware

Source: https://www.venturelab.swiss/OBaris-The-Venture-Leader-Biotech-providing-a-painless-alternative-to-injectable-drugs/